Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoproliferative Disorders × Mesna × Clear all

Sponsor

Conditions

Lymphoma, Non-Hodgkin 11 Lymphoma 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Leukemia 10 Hodgkin Disease 7 Sarcoma 6 Hematologic Neoplasms 6 Neoplasms 5 Myelodysplastic Syndromes 5 Leukemia, Myeloid, Acute 5 Neuroblastoma 4 Multiple Myeloma 4 Lymphoma, Mantle-Cell 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Myeloproliferative Disorders 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Breast Neoplasms 3 Vomiting 2 Testicular Neoplasms 2 Osteosarcoma 2 Neoplasm Metastasis 2 Nausea 2 Thalassemia 1 Teratoma 1 Seminoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Ovarian Germ Cell Cancer 1 Neuroectodermal Tumors, Primitive, Peripheral 1

Interventions

blinatumomab 4 Rituximab 3 ponatinib 2 Vorinostat 2 Vincristine 2 Prednisone 2 Ifosfamide 2 Etoposide 2 Doxorubicin 2 Cyclophosphamide 2 Brentuximab Vedotin 2 Bortezomib 2 tetulomab tetraxetan lu-177 1 pegaspargase 1 ibritumomab tiuxetan 1 cobomarsen 1 asparaginase erwinia chrysanthemi recombinant 1 acalabrutinib 1 Methotrexate 1 Melphalan 1 Lutetium 1 KW-2478 1 Imatinib Mesylate 1 Hsp90 inhibitor KU757 1 Dexamethasone 1 Daunorubicin 1 Cytarabine 1 Carmustine 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡